4:06 pm Theravance announces initiation of Phase 2b study with TD-4208, an investigational LAMA for the treatment of COPD
moreView todays social media effects on THRXView the latest stocks trending across Twitter. Click to view dashboardSee who Theravance is hiring next, click here to view […]